Skip to main content
Clinical Trials/CTRI/2020/09/027654
CTRI/2020/09/027654
Completed
未知

A clinical study to evaluate the safety and feasibility of outpatient induction therapy in newly diagnosed adolescent and adult acute myeloid leukemia (AML). - AML Study

Tata Research Administrative Council TRAC0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C920- Acute myeloblastic leukemia
Sponsor
Tata Research Administrative Council TRAC
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Tata Research Administrative Council TRAC

Eligibility Criteria

Inclusion Criteria

  • 1\. Newly diagnosed AML and high\-risk myelodysplastic syndrome.
  • 2\. Planned treatment with Cytarabine and daunomycin with or without midostaurin
  • 3\. Normal organ function and no active infection in lungs
  • 4\. Accommodation facility within one hour distance from hospital.

Exclusion Criteria

  • 1\. platelet count less than 10000 after 1 unit SDP transfusion
  • 2\. Clinical internal/visceral bleeding manifestations like hematemesis, melaena, hematuria
  • 3\. History of hypersensitivity/ allergy to blood/ blood products, chemotherapeutic drugs and antibiotics
  • 4\. Acute medical emergencies like diabetic ketosis, diabetic ketoacidosis, hypertensive urgency/ emergency, acute kidney injury etc
  • 5\. Relapsed AML case patients

Outcomes

Primary Outcomes

Not specified

Similar Trials